These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32748963)

  • 21. Presence and short-term persistence of SARS-CoV-2 neutralizing antibodies in COVID-19 convalescent plasma donors.
    Annen K; Morrison TE; DomBourian MG; McCarthy MK; Huey L; Merkel PA; Andersen G; Schwartz E; Knight V
    Transfusion; 2021 Apr; 61(4):1148-1159. PubMed ID: 33452828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study.
    Alsharidah S; Ayed M; Ameen RM; Alhuraish F; Rouheldeen NA; Alshammari FR; Embaireeg A; Almelahi M; Adel M; Dawoud ME; Aljasmi MA; Alshammari N; Alsaeedi A; Al-Adsani W; Arian H; Awad H; Alenezi HA; Alzafiri A; Gouda EF; Almehanna M; Alqahtani S; Alshammari A; Askar MZ
    Int J Infect Dis; 2021 Feb; 103():439-446. PubMed ID: 33285283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma.
    Vandeberg P; Cruz M; Diez JM; Merritt WK; Santos B; Trukawinski S; Wellhouse A; Jose M; Willis T
    Transfusion; 2021 Jun; 61(6):1705-1709. PubMed ID: 33715160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoting access to COVID-19 convalescent plasma in low- and middle-income countries.
    Bloch EM; Goel R; Montemayor C; Cohn C; Tobian AAR
    Transfus Apher Sci; 2021 Feb; 60(1):102957. PubMed ID: 32972861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?
    Bloch EM; Tobian AAR; Shoham S; Hanley DF; Gniadek TJ; Cachay ER; Meisenberg BR; Kafka K; Marshall C; Heath SL; Shenoy A; Paxton JH; Levine A; Forthal D; Fukuta Y; Huaman MA; Ziman A; Adamski J; Gerber J; Cruser D; Kassaye SG; Mosnaim GS; Patel B; Metcalf RA; Anjan S; Reisler RB; Yarava A; Lane K; McBee N; Gawad A; Raval JS; Zand M; Abinante M; Broderick PB; Casadevall A; Sullivan D; Gebo KA
    Transfusion; 2022 May; 62(5):933-941. PubMed ID: 35352362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic.
    Al-Riyami AZ; Burnouf T; Wood EM; Devine DV; Oreh A; Apelseth TO; Goel R; Bloch EM; van Den Berg K; Getshen M; Louw V; Ang AL; Lee CK; Rahimi-Levene N; Stramer SL; Vassallo R; Schulze TJ; Patidar GK; Pandey HC; Dubey R; Badawi M; Hindawi S; Meshi A; Matsushita T; Sorrentino E; Grubovic Rastvorceva RM; Bazin R; Vermeulen M; Nahirniak S; Tsang HC; Vrielink H; Triyono T; Addas-Carvalho M; Hećimović A; Torres OW; Mutindu SM; Bengtsson J; Dominguez D; Sayedahmed A; Hanisa Musa R; Gautam B; Herczenik E; So-Osman C;
    Vox Sang; 2022 Jun; 117(6):822-830. PubMed ID: 35262978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry.
    De Silvestro G; Marson P; La Raja M; Cattelan AM; Guarnieri G; Monticelli J; Tiberio I; Vianello A; Gandini G; Gessoni G; Fiorin F; Sardella C; Astolfi L; Saia M;
    Eur J Intern Med; 2022 Mar; 97():42-49. PubMed ID: 34980505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-institutional experience with COVID-19 convalescent plasma in children.
    Jacquot C; Gordon O; Noland D; Donowitz JR; Levy E; Jain S; Willis Z; Rimland C; Loi M; Arrieta A; Annen K; Drapeau N; Osborne S; Ardura MI; Arora S; Zivick E; Delaney M
    Transfusion; 2023 May; 63(5):918-924. PubMed ID: 36965173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of SARS-CoV-2-independent immunoregulatory activity of COVID-19 convalescent plasma.
    Brox R; Achenbach S; Hackstein H
    Transfusion; 2021 Nov; 61(11):3087-3093. PubMed ID: 34546583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment.
    Algora M; Mehmood T; Madison DL; AlAmeri J; Abuzakouk M; Tagamtam M; Acena L; Totaan G; Grabski G; Oumeziane N; Rajani P; Taylor L; Guzman J; AbdelWareth LO
    Arch Pathol Lab Med; 2021 Dec; 145(12):1479-1484. PubMed ID: 34407176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds.
    Larkey NE; Ewaisha R; Lasho MA; Roforth MM; Granger D; Jerde CR; Wu L; Gorsh A; Klassen SA; Senefeld JW; Joyner MJ; Baumann NA; Theel ES; Mills JR
    Microbiol Spectr; 2022 Aug; 10(4):e0115422. PubMed ID: 35862939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
    Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
    Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualifying coronavirus disease 2019 convalescent plasma donors in Israel.
    Izak M; Gendelman V; Bransburg-Zabary S; Stoyanov E; Gat R; Cohen D; Chen J; Maor Y; Benov A; Lev B; Zimhony O; Shinar E
    Vox Sang; 2022 Feb; 117(2):185-192. PubMed ID: 34125976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial".
    Teofili L; Landolfi R; Cingolani A; Antinori A; Vecchiet J; Sanguinetti M; Gasbarrini A; Pasciuto T; Orlando N; Lamonica S
    Trials; 2020 Oct; 21(1):875. PubMed ID: 33092632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma.
    Estcourt LJ; Cohn CS; Pagano MB; Iannizzi C; Kreuzberger N; Skoetz N; Allen ES; Bloch EM; Beaudoin G; Casadevall A; Devine DV; Foroutan F; Gniadek TJ; Goel R; Gorlin J; Grossman BJ; Joyner MJ; Metcalf RA; Raval JS; Rice TW; Shaz BH; Vassallo RR; Winters JL; Tobian AAR
    Ann Intern Med; 2022 Sep; 175(9):1310-1321. PubMed ID: 35969859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early mortality benefit with COVID-19 convalescent plasma: a matched control study.
    Shenoy AG; Hettinger AZ; Fernandez SJ; Blumenthal J; Baez V
    Br J Haematol; 2021 Feb; 192(4):706-713. PubMed ID: 33482025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a SARS-CoV-2 RNA RT-PCR assay for high-throughput testing in blood of COVID-19 convalescent plasma donors and patients.
    Strasser EF; Steininger PA; Korn K; Achenbach S; Tenbusch M; Cunningham S; Zimmermann R; Überla K; Hackstein H
    Transfusion; 2021 Feb; 61(2):368-374. PubMed ID: 33125162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities.
    Al-Riyami AZ; Schäfer R; van den Berg K; Bloch EM; Estcourt LJ; Goel R; Hindawi S; Josephson CD; Land K; McQuilten ZK; Spitalnik SL; Wood EM; Devine DV; So-Osman C
    Vox Sang; 2021 Jan; 116(1):88-98. PubMed ID: 32542847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.